|
![]() |
|||||||||||
![]() |
||||||||||||
Sexually Transmitted Diseases |
||||||||||||
Figure 16. Gonorrhea — Rates by race and ethnicity: United States, 1981–2003 and the Healthy People 2010 target
Figure 17. Gonorrhea — Age- and sex-specific rates: United States, 2003
Figure 18. Gonorrhea — Positivity among 15- to 24-year-old women tested in family planning clinics by state: United States and outlying areas, 2003
Figure 19. Gonococcal Isolate Surveillance Project (GISP) — Location of participating clinics and regional laboratories: United States, 2003 Figure 20. Gonococcal Isolate Surveillance Project (GISP) — Penicillin and tetracycline resistance among GISP isolates, 2003
Figure 21. Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance or intermediate resistance to ciprofloxacin, 1990–2003
Figure 22. Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance to ciprofloxacin by sexual behavior, 2001–2003
Page last modified: November 15, 2004 Page last reviewed: November 15, 2004 Historical Document Content Source: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention |
||||||||||||
|
||||||||||||
![]() |